Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care.
![Biospace-image-thumb[1]](https://lexagene.com/wp-content/uploads/2021/11/Biospace-image-thumb1.png)
BioSpace Coverage on LexaGene EUA Studies
LexaGene
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
Upcoming Events
No events in this category to show at this time.
Latest Resources
In this study, slow-growing bacterium and typical contaminant, C. acnes, was challenged for microbial detection utilizing both LexaGene’s MiQLab System and anaerobic culture.